TREATMENT OF PARKINSON'S SYNDROME WITH L-DOPA A DOUBLE BLIND STUDY
Top Cited Papers
- 29 January 2009
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 42 (3) , 367-372
- https://doi.org/10.1111/j.1600-0404.1966.tb01188.x
Abstract
Twenty-five patients with Parkinson''s syndrome were given 1.5 mg L-dopa/kg [dihydro-phenylalamine] bw in a double blind study. Several factors that mav have influenced the results are discussed. This dose of L-dopa is not superior to saline in relieving the symptoms of the syndrome. However, it is possible that a larger dose or a combination with a MAO [monoamine oxidase]-inhibitor might give more satisfactory therapeutic results though this probably is of more theoretical than practical interest today.This publication has 13 references indexed in Scilit:
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964
- Dihydroxyphenylalanine in Extrapyramidal DiseaseJAMA, 1963
- Erfahrungen mit L-Dopa in der Therapie des ParkinsonismusEuropean Neurology, 1963
- Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-AkineseArchiv Fur Psychiatrie Und Nervenkrankheiten, 1962
- A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONʼS DISEASEJournal of Nervous & Mental Disease, 1961
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960
- Über die Wirkungen des L-Dopa beim Menschen und deren Beeinflussung durch Reserpin, Chlorpromazin, Iproniazid und Vitamin B6Klinische Wochenschrift, 1960
- Occurrence and distribution of dopamine in brain and other tissuesCellular and Molecular Life Sciences, 1959
- On the Presence of 3-Hydroxytyramine in BrainScience, 1958
- 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine AntagonistsNature, 1957